Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04878029
Title Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Emory University
Indications

transitional cell carcinoma

Therapies

Cabozantinib + Enfortumab vedotin-ejfv

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
Emory University Hospital/Winship Cancer Institute Recruiting Atlanta Georgia 30322 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field